ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,290Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 393

$784K Total Retail Price of All Prescriptions

Rank: 14 out of 393

1,226 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 1,226 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 1,226 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 19,714 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 1,128 1,073 1 1
OMEPRAZOLE 964 889 2 6
LISINOPRIL 881 829 3 2
HYDROCODONE-ACETAMINOPHEN 853 790 S3 4 5
LEVOTHYROXINE SODIUM 820 758 5 3
AMLODIPINE BESYLATE 651 615 6 4
ATENOLOL 586 563 7 13
METFORMIN HCL 558 514 8 7
LOVASTATIN 451 435 9 14
WARFARIN SODIUM 424 403 10 17
METOPROLOL TARTRATE 402 395 11 9
HYDROCHLOROTHIAZIDE 358 325 12 10
ALENDRONATE SODIUM 356 355 13 16
TERAZOSIN HCL 350 334 14 38
FUROSEMIDE 341 328 15 8
PRAVASTATIN SODIUM 330 302 16 18
GABAPENTIN 300 254 17 15
GLIMEPIRIDE 269 245 18 39
POTASSIUM CHLORIDE 249 226 19 20
LOSARTAN POTASSIUM 248 228 20 12
CITALOPRAM HBR 247 219 21 23
ALLOPURINOL 222 209 22 26
ZOLPIDEM TARTRATE 218 200 23 11
BISOPROLOL-HYDROCHLOROTHIAZIDE 217 217 24 136
METOPROLOL SUCCINATE 216 208 25 22
VENTOLIN HFA 211 169 26 42
TRAMADOL HCL 197 173 27 30
FINASTERIDE 194 194 28 60
RANITIDINE HCL 188 185 29 29
FLUTICASONE PROPIONATE 184 157 30 27
CARVEDILOL 179 170 31 21
LOSARTAN-HYDROCHLOROTHIAZIDE 177 156 32 31
ATORVASTATIN CALCIUM 175 162 33 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 170 160 34 24
ISOSORBIDE MONONITRATE ER 161 137 35 67
FLUOXETINE HCL 160 151 36 37
BENAZEPRIL HCL 154 153 37 40
CLOPIDOGREL 148 138 38 33
GLYBURIDE 138 135 R 39 46
SPIRIVA 136 107 40 41
FENOFIBRATE 132 107 41 43
METFORMIN HCL ER 124 105 42 63
DIGOXIN 122 116 43 66
GLIPIZIDE 120 104 44 32
PLAVIX 120 115 44 51
TAMSULOSIN HCL 118 118 46 25
TRAZODONE HCL 108 92 47 47
ACTOS 105 102 48 78
BENAZEPRIL-HYDROCHLOROTHIAZIDE 105 105 48 179
SERTRALINE HCL 101 89 50 28
POLYETHYLENE GLYCOL 3350 95 92 51 99
PREDNISONE 90 89 52 65
TRIAMTERENE-HCTZ 90 86 52 49
GEMFIBROZIL 89 86 54 62
DILTIAZEM ER 84 84 55 107
NAPROXEN 80 78 56 85
IBUPROFEN 79 74 57 55
OXYCODONE HCL-ACETAMINOPHEN 76 54 S2 58 54
OXYBUTYNIN CHLORIDE ER 74 74 59 122
BISOPROLOL FUMARATE 74 74 59 162
LANTUS 72 61 61 73
MIRTAZAPINE 72 72 61 89
AMITRIPTYLINE HCL 71 71 R 63 72
MECLIZINE HCL 69 67 64 163
VERAPAMIL ER 68 65 65 86
PEN NEEDLE 68 67 65 81
MORPHINE SULFATE ER 67 47 S2 67 48
GLIPIZIDE ER 66 65 68 76
CLONIDINE HCL 66 64 68 50
GLYBURIDE-METFORMIN HCL 66 55 R 68 125
GALANTAMINE HBR 65 65 71 267
AZITHROMYCIN 62 60 72 35
INSULIN SYRINGE 62 62 72 110
OXYCODONE-ACETAMINOPHEN 62 49 S2 72 71
PAROXETINE HCL 62 46 72 61
TIZANIDINE HCL 60 43 76 97
LANTUS SOLOSTAR 58 53 77 74
PROPRANOLOL HCL 57 46 78 134
FAMOTIDINE 56 42 79 70
KLOR-CON 10 56 56 79 113
ROPINIROLE HCL 55 50 81 121
TRAMADOL HCL-ACETAMINOPHEN 54 53 82 139
QVAR 54 54 82 101
BENICAR HCT 52 52 84 161
NAMENDA 51 51 85 59
LABETALOL HCL 51 40 85 143
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.